Sustained and regulated gene expression by Tet-inducible "all-in-one" retroviral vectors containing the HNRPA2B1-CBX3 UCOE


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
02 2019
Historique:
received: 09 09 2018
revised: 01 11 2018
accepted: 06 11 2018
pubmed: 6 12 2018
medline: 7 3 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Genetic modification of induced pluripotent stem (iPS) cells may be necessary for the generation of effector cells for cellular therapies. Hereby, it can be important to induce transgene expression at restricted and defined time windows, especially if it interferes with pluripotency or differentiation. To achieve this, inducible expression systems can be used such as the tetracycline-inducible retroviral vector system, however, retroviral expression can be subjected to epigenetic silencing or to position-effect variegation. One strategy to overcome this is the incorporation of ubiquitous chromatin opening elements (UCOE

Identifiants

pubmed: 30508767
pii: S0142-9612(18)30783-X
doi: 10.1016/j.biomaterials.2018.11.006
pii:
doi:

Substances chimiques

Chromatin 0
Chromosomal Proteins, Non-Histone 0
Cytokines 0
Heterogeneous-Nuclear Ribonucleoprotein Group A-B 0
Receptors, Thrombopoietin 0
Phosphoglycerate Kinase EC 2.7.2.3
Tetracycline F8VB5M810T
Doxycycline N12000U13O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

486-499

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Katharina Cullmann (K)

Research Group for Gene Modification in Stem Cells, Div. of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany.

Kaj E C Blokland (KEC)

Research Group for Gene Modification in Stem Cells, Div. of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany.

Attila Sebe (A)

Div. of Medical Biotechnology, Paul-Ehrlich-Institute, Langen, Germany.

Franziska Schenk (F)

Research Group for Gene Modification in Stem Cells, Div. of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany.

Zoltán Ivics (Z)

Div. of Medical Biotechnology, Paul-Ehrlich-Institute, Langen, Germany.

Niels Heinz (N)

Research Group for Gene Modification in Stem Cells, Div. of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany.

Ute Modlich (U)

Research Group for Gene Modification in Stem Cells, Div. of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany. Electronic address: Ute.modlich@pei.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH